Article
Liquid biopsy for the detection of H3K27m in patients with brainstem tumors.
Neurosurgical review - 26 May 2025
Gavrjushin A V, Papusha L I, Veselkov A A, Zaitseva M A, Khukhlaeva E A, Konovalov A N, Druy A E
Abstract excerpt
The treatment of diffuse brainstem tumors is prescribed in most cases without morphological or molecular genetic verification. "Liquid biopsy" is a minimally invasive technique that provides information about the biology of tumors without a standard biopsy. We set out to determine the informativeness of this diagnostic method for detecting H3K27 and BRAF V600E mutations in patients with diffuse brainstem tumors....
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
